Učitavanje...
Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care
This retrospective observational analysis of health claims data compares the safety, effectiveness, and cost of biosimilar filgrastim and filgrastim.
Spremljeno u:
| Izdano u: | JAMA Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Medical Association
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6440708/ https://ncbi.nlm.nih.gov/pubmed/30383135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.5090 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|